Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: Is there a relationship?

International Journal of Immunopathology and Pharmacology

Volumn 20, Issue 1, 2007, Pages 163-172

  Di Bonaventura, G ^a   Piccolomini, R ^a   Pompilio, A ^a   Zappacosta, R ^a   Piccolomini, M ^a   Neri, M ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Cytokines; Helicobacter pylori; Ischemic heart disease

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CYTOKINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BACTERIUM DETECTION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS; STOMACH MUCOSA;

EID: 33947720023     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200702000119     Document Type: Article

References (55)

1. World Health Organization Statistics. 1997-1999 World Health Statistics Annual. Available at: www3.who.int/whosis.
2. Nieminen M.S., K. Mattila and V. Valtonen. 1993. Infection and inflammation as a risk factor for myocardial infection. Eur. Heart. J. 14(S):12.
3. Ross R. 1999. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:115.
4. Mendall M.A., P. Patel, M. Asante, L. Ballam, J. Morris, D.P. Stracham, A.J. Camm and T.C. Northfield. 1997. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 78:273.
5. Lowe G.D. 2001. The relationship between infection, inflammation, and cardiovascular disease: an overview. Ann. Periodontal. 6:1.
6. Cesari M., B.W. Penninx, A.B. Newman, S.B. Kritchevsky, B.J. Nicklas, K. Sutton-Tyrrell, S.M. Rubin, J. Ding, E.M. Simonsick, T.B. Harris and M. Pahor. 2003. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 108:2317.
7. Pradhan A.D., J.E. Manson, J.E. Rossouw, D.S. Siscovick, C.P. Mouton, N. Rifai, R.B. Wallace, R.D. Jackson, M.B. Pettinger and P.M. Ridker. 2002. Inflammatory biomarkers, hormone replacement therapy and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 288:980.
8. Danesh J., R. Collins and R. Peto. 1997. Chronic infections and coronary heart disease: is there a link ? Lancet 350:430.
9. Anestad G., O. Scheel and O. Hungnes. 1997. Chronic infections and coronary heart disease. Lancet 350:1028.
10. Patel P., M. Mendall, D. Carrington, D. Strachan, E. Leatham, N. Molineaux, J. Levy, C. Blakeston, C.A. Seymour, A.J. Camm et al. 1995. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br. Med. J. 311:711.
11. Liuba P., E. Pesonen, I. Paakkari, S. Batra, L. Andersen, A. Forslid, S. Yla-Herttuala, K. Persson, T. Wadstrom, X. Wang and R. Laurini. 2003. Co-infection with Chlamydia pneumoniae and Helicobacter pylori results in vascular endothelial dysfunction and enhanced VCAM-1 expression in apoE-knockout mice. J. Vasc. Res. 40:115.
12. Grahame-Clarke C., N.N. Chan, D. Andrew, G.L. Ridgway, D.J. Betteridge, V. Emery, H.M. Colhoun and P. Vallance. 2003. Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation 108:678.
13. Mendall M.A., P.M. Goggin, N. Molineaux, J. Levy, T. Toosy, D. Strachan, A.J. Camm and T.C. Northfield. 1994. Relation of Helicobacter pylori infection and coronary heart disease. Br. Heart J. 71:437.
14. Figura N., A. Palazzuoli, S. Faglia, C. Lenzi, F. Borrello, V. Palazzuoli, R. Nami, N. Dal Canto, F. De Regis, D. Vaira, L. Gennari, N. Giordano and C. Gennari. 2002. Infection by CagA-positive Helicobacter pylori strains in patients with ischemic heart disease: prevalence and association with exercise-induced electrocardiographic abnormalities. Dig. Dis. Sci. 47:831.
15. Torgano G., R. Cosentini, C. Mandelli, R. Perondi, F. Blasi, G. Bertinieri, T.V. Tien, G. Ceriani, P. Tarsia, C. Arosio and M.L. Ranzi. 1999. Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease. Circulation 99:1555.
16. Strachan D.P. 1998. Non-gastrointestinal consequences of Helicobacter pylori infection. Br. Med. Bull. 54:87.
17. Pellicano R., S. Fagoonee, M. Pizzetto and A. Ponzetto. 2003. Helicobacter pylori and coronary heart disease: which directions for future studies? Crit. Rev. Microbiol. 29:351.
18. Whincup P., J. Danesh, M. Walker, L. Lennon, A. Thomson, P. Appleby, C. Hawkey and J. Atherton. 2000. Prospective study of potentially virulent strains of Helicobacter pylori and coronary disease in middle-aged men. Circulation 101:1647.
19. Aguejouf O., K. Mayo, L. Monteiro, F. Doutremepuich, C. Doutremepuich and F. Megraud. 2003. Increase of arterial thrombosis parameters in chronic Helicobacter pylori infection in mice. Tromb. Res. 108:245.
20. Regnstrom J., S. Jovinge, P. Bavenholm, C.G. Ericsson, U. De Faire, A. Hamsten, M.L. Hellenius, J. Nilsson and P. Tornvall. 1998. Helicobacter pylori seropositivity is not associated with inflammatory parameters, lipid concentration and degree of coronary artery disease. J. Intern. Med. 243:109.
21. Lamb D.J., W. El-Sankary and G.A. Ferns. 2003. Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation. Atherosclerosis 167:177.
22. Sung J.J. and J.E. Sanderson. 1996. Hyperhomocisteinaemia, Helicobacter pylori, and coronary heart disease. Heart 76:305.
23. Crabtree J.E., T.M. Shalcross, R.V. Heatley and J.I. Wyatt. 1991. Mucosal tumour necrosis factor "a" and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 32:1473.
24. Klausz G., A. Tiszai, L. Tiszlavicz, Z. Gyulai, Z. Lenart, J. Lonovics and Y. Mandi. 2003. Local and peripheral cytokine response and CagA status of Helicobacter pylori-positive patients with duodenal ulcer. Eur. Cytokine Netw. 14:143.
25. Isomoto H., Y. Nishi, A. Wang, F. Takeshima, K. Omagari, Y. Mizuta, S. Shikuwa, I. Murata and S. Kohno. 2004. Mucosal concentrations of proinflammatory cytokines and chemokines at gastric cardia: implication of Helicobacter pylori infection and gastroesophageal reflux. Am. J. Gastroenterol. 99:1063.
26. Tanahashi T., M. Kita, T. Kodama, Y. Yamaoka, N. Sawai, T. Ohno, S. Mitsufuji, Y.P. Wei, K. Kashima and J. Imanishi. 2000. Cytokine expression and production by purified Helicobacter pylori urease in human gastric epithelial cells. Infect. Immun. 68:664.
27. Mehmet N., M. Refik, M. Harputluoglu, Y. Ersoy, N.E. Aydin and B. Yildirim. 2004. Serum and gastric fluid levels of cytokines and nitrates in gastric diseases infected with Helicobacter pylori. New Microbiol. 27:139.
28. Bayraktaroglu T., A.S. Aras, S. Aydemir, C. Davutoglu, Y. Ustundag, H. Atmaca and A. Borazan. 2004. Serum levels of tumor necrosis factor-alpha, interleukin-6 and interleukin-8 are not increased in dyspeptic patients with Helicobacter pylori-associated gastritis. Mediators Inflamm. 13:25.
29. Russo F., E. Jirillo, C. Clemente, C. Messa, M. Chiloiro, G. Riezzo, L. Amati, L. Caradonna and A. Di Leo. 2001. Circulating cytokines and gastrin levels in asymptomatic subjects infected by Helicobacter pylori (H. pylori). Immunopharmacol. Immunotoxicol. 23:13.
30. Piccolomini R., G. Di Bonaventura, D. Festi, G. Catamo, F. Laterza and M. Neri. 1997. Optimal combination of media for primary isolation of Helicobacter pylori from gastric biopsy specimens. J. Clin. Microbiol. 35:1541.
31. Di Bonaventura G., M. Neri, D. Angelucci, S. Rosini, M. Piccolomini and R. Piccolomini. 2004. Detection of Helicobacter pylori by PCR on gastric biopsy specimens taken for CP test: comparison with histopathological analysis. Int. J. Immunopathol. Pharmacol. 17:77.
32. Rus H.G., F. Niculescu and R. Vlaicu. 1991. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 89:247.
33. Wong G.G. and S.C. Clark. 1998. Multiple actions of interleukin-6 within a cytokine network. Immnunol. Today 9:137.
34. Conti P., D. Kempuraj, M. Di Gioacchino, W. Boucher, R. Letourneau, K. Kandere, R.C. Barbacane, M. Reale, M. Felaco, S. Frydas and T.C. Theoharides. 2002. Interleukin-6 and mast cells. Allergy Asthma Proc. 23:331.
35. McCarty M.F. 1999. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: downregulation with essential fatty acids, ethanol, and pentoxifylline. Med. Hypotheses 52:465.
36. Gionchetti P., D. Vaira, M. Campieri, J. Holton, M. Menegatti, A. Belluzzi, E. Bertinelli, M. Ferretti, C. Brignola and M. Miglioli. 1994. Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients. Am. J. Gastroenterol. 89:883.
37. Dinarello C.A. 1997. Interleukin-1. Cytokine Growth Factor Rev. 8:253.
38. Conti P. 1991. Interleukin-1 (IL-1) and interleukin-1 receptor antagonist (IL-1ra). Ann. Med. Interne (Paris) 142:521.
39. Francis S.E., N.J. Camp, R.M. Dewberry, J. Gunn, P. Syrris, N.D. Carter, S. Jeffery, J.C. Kaski, D.C. Cumberland, G.W. Duff and D.C. Crossman. 1999. Interleukin-1 Receptor Antagonist Gene Polymorphism and Coronary Artery Disease. Circulation 99:861.
40. Dewberry R., H. Holden, D. Crossman and S. Francis. 2000. Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 20:2394.
41. Waehre T., A. Yndestad, C. Smith, T. Haug, S.H. Tunheim, L. Gullestad, S.S. Froland, A.G. Semb, P. Aukrust and J.K. Damas. 2004. Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors. Circulation 109:1966.
42. Sahni A., M. Guo, S.K. Sahni and C.W. Francis. 2004. Interleukin-1β but not IL-1α binds to fibrinogen and fibrin and has enhanced activity in the bound form. Blood 104:409.
43. Jung H.C., J.M. Kim, I.S. Song and C.Y. Kim. 1997. Helicobacter pylori induces an array of proinflammatory cytokines in human gastric epithelial cells: quantification of mRNA for interleukin-8, -1 alpha/beta, granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant protein-1 and tumour necrosis factor-alpha. J. Gastroenterol. Hepatol. 12:473.
44. Nelson P.J. and A.M. Krensky. 1998. Chemokines, lymphocytes and viruses: what goes around comes around. Curr. Opin. Immunol. 10:265.
45. Kowalski M., P.C. Konturek, P. Pieniaek, E. Karczewska, A. Kluczka, R. Grove, W. Kranig, R. Nasseri, J. Thale, E.G. Hahn and S.J. Konturek. 2001. Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Dig. Dis. Liver Dis. 33:222.
46. Yamaguchi H., T. Osaki, N. Kurihara, M. Kitajima, M. Kai, M. Takahashi, H. Taguchi and S. Kamiya. 1999. Induction of secretion of interleukin-8 from human gastric epithelial cells by heat-shock protein 60 homologue of Helicobacter pylori. J. Med. Microbiol. 48:927.
47. Yeo M., H.K. Park, K.M. Lee, K.J. Lee, J.H. Kim, S.W. Cho and K.B. Hahm. 2004. Blockage of HSP 90 modulates Helicobacter pylori-induced IL-8 productions through the inactivation of transcriptional factors of AP-1 and NF-kappaB. Biochem. Biophys. Res. Commun. 320:816.
48. Peek R.M., G.G. Miller, K.T. Tham, G.I. Perez-Perez, X. Zhao, J.C. Atherton and M.J. Blaser. 1995. Heightened inflammatory response and cytokine expression in vivo to CagA+ Helicobacter pylori strains. Lab. Invest. 73:760.
49. Yamaoka Y., M. Kita, T. Kodama, N. Sawai, K. Kashima and J. Imanishi. 1997. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 41:442.
50. Pasceri V., G. Cammarota, G. Patti, L. Cuoco, A. Gasbarrini, R.L. Grillo, G. Fedeli, G. Gasbarrini and A. Maseri. 1998. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 97:1675.
51. Murray L.J., K.B. Bamford, F. Kee, D. McMaster, F. Cambien, J. Dallongeville and A. Evans. 2000. Infection with virulent strains of Helicobacter pylori is not associated with ischaemic heart disease: evidence from a population-based case-control study of myocardial infarction. Atherosclerosis 149:379.
52. Aceti A., R. Are, G. Sabino, L. Fenu, C. Pasquazzi, G. Quaranta, B. Zechini and P. Terrosu. 2004. Helicobacter pylori active infection in patients with acute coronary heart disease. J. Infect. 49:8.
53. Hoffmeister A., D. Rothenbacher, G. Bode, K. Persson, W. Marz, M.A. Nauck, H. Brenner, V. Hombach and W. Koenig. 2001. Current infection with Helicobacter pylori but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler. Thromb. Vasc. Biol. 21:421.
54. Niemela S., T. Karttunen, T. Korhonen, E. Laara, R. Karttunen, M. Ikaheimo and Y.A. Kesaniemi. 1996. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 75:573.
55. Feingold K. and C. Grunfeld. 1992. Role of cytokines in inducing hyperlipidemia. Diabetes 41: 97.